An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone started taking human growth hormone (HGH) for about two months, then got a blood test that measured IGF‑1 at 159 ng/mL and is unsure what to do next. They didn’t get a “before” (baseline) IGF‑1 test, so they don’t know whether 159 is higher than their natural level. Now they’re wondering whether to increase their HGH dose or switch to a different drug called tesamorelin. HGH (human growth hormone) is a hormone your body makes in the brain that helps control growth, metabolism, and tissue repair. It acts partly by causing the liver and other tissues to make another chemical called IGF‑1 (insulin‑like growth factor 1). Doctors often measure IGF‑1 in the blood because it’s a more stable indicator of how much growth hormone effect your body is getting. Tesamorelin is not HGH itself; it’s a synthetic drug that stimulates your brain to release more of your own growth hormone. Think of HGH as directly adding the hormone, and tesamorelin as nudging your body to make more of it. What this person’s test shows is one single IGF‑1 number after two months of taking HGH. The raw number, 159 ng/mL, has meaning only compared to the lab’s reference range and the person’s age and sex. Without a baseline test from before they started, you can’t tell whether the level went up, stayed the same, or is within the expected range for them. Also, a single test doesn’t reveal overall benefits or harms; it doesn’t tell you whether they’re getting better energy, muscle, or bone effects, or if they’re experiencing side effects. There’s no information here about how much HGH they were taking, how they were sourcing it, or whether a doctor is supervising the treatment — all important details for interpreting the lab and making a safe plan. Why this matters for an everyday person: IGF‑1 is used to guide dosing and safety when people are on growth hormone. Too low might mean the dose is ineffective, and too high raises risk for side effects like joint pain, swelling, insulin resistance (problems with blood sugar), and possibly other longer-term risks. If someone is self-administering HGH or getting it from an unofficial source, a neutral IGF‑1 result doesn’t guarantee safety. Switching to tesamorelin would be a different strategy; it may increase natural GH production but can have its own effects and is typically prescribed for specific conditions. Any change in dose or switching drugs should ideally be made under medical supervision with proper labs and monitoring. Important caveats: IGF‑1 reference ranges vary by lab and by age, so “159 ng/mL” may be normal for some people and low or high for others. Self-treating with HGH carries risks, especially without baseline labs and ongoing monitoring. Side effects can include fluid retention, joint pain, carpal tunnel symptoms, increased blood sugar, and others. Tesamorelin is a prescription drug and not a guaranteed safer substitute. Because the story lacks details (baseline levels, dose, source, symptoms), there isn’t a clear medical recommendation here — the safest next step is to get baseline and follow-up labs, stop unsupervised dosing, and consult a licensed clinician who can interpret the number in context and advise on dosing or alternative therapies. Bottom line: One IGF‑1 result after two months of HGH doesn’t tell you enough — get proper baseline and follow‑up tests and talk to a doctor before changing dose or switching drugs.
Source: r/Peptides